Also trades as: KTTAW (NASDAQ) · $vol 0M
KTTA NASDAQ
Pasithea Therapeutics Corp.
1W: -9.9%
1M: -2.0%
3M: +0.3%
YTD: -41.0%
1Y: -26.5%
3Y: -90.2%
$0.70
-0.07 (-8.75%)
Pre-Market: $0.75 (+0.05, +7.32%)
Weekly Expected Move ±11.8%
$1
$1
$1
$1
$1
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Last Earnings
2026-03-30
EPS
$-0.89
▼ Miss -394.4%
Revenue
$100K
Est (actual pending)
Next Earnings
2026-08-13
EPS Estimate
$-0.45
Range: $-0.45 - $-0.45
Revenue Estimate
$300K
1 analysts
Estimate vs Actual
Earnings Surprise History
3/17
EPS Beats
1/17
Revenue Beats
18%
EPS Beat Rate
6%
Rev Beat Rate
Wall Street Forward Estimates
Quarterly
Annual
Estimate Revisions
Recent Revisions
| Date | Period | Fiscal Date | EPS Old | EPS New | Change | Rev Old | Rev New |
|---|---|---|---|---|---|---|---|
| 2026-04-09 | quarter | 2026-03-31 | $-1.00 | $-0.45 | ▲ 0.55 | $100,000 | $100,000 |
| 2026-04-09 | quarter | 2026-06-30 | $-0.40 | $-0.45 | ▼ 0.05 | $300,000 | $300,000 |
| 2026-04-09 | quarter | 2026-12-31 | $-3.40 | $-0.48 | ▲ 2.92 | $200,000 | $200,000 |
| 2026-04-09 | annual | 2028-12-31 | $— | $-2.30 | ▼ 2.30 | $— | $— |
| 2026-04-09 | annual | 2027-12-31 | $-0.87 | $-2.10 | ▼ 1.23 | $— | $— |
| 2026-04-09 | quarter | 2026-09-30 | $-2.20 | $-0.48 | ▲ 1.72 | $200,000 | $200,000 |
| 2026-04-09 | annual | 2025-12-31 | $-0.68 | $-1.50 | ▼ 0.82 | $— | $— |
| 2026-04-09 | annual | 2026-12-31 | $-0.82 | $-1.86 | ▼ 1.04 | $— | $— |
| 2026-04-01 | quarter | 2028-03-31 | $— | $-3.80 | ▼ 3.80 | $— | $— |
| 2026-04-01 | quarter | 2027-12-31 | $— | $-3.60 | ▼ 3.60 | $— | $— |
| 2026-04-01 | quarter | 2027-03-31 | $— | $-3.40 | ▼ 3.40 | $— | $300,000 |
| 2026-04-01 | quarter | 2026-12-31 | $— | $-3.40 | ▼ 3.40 | $— | $200,000 |
| 2026-04-01 | quarter | 2026-03-31 | $— | $-1.00 | ▼ 1.00 | $— | $100,000 |
| 2026-04-01 | quarter | 2025-12-31 | $— | $-0.18 | ▼ 0.18 | $— | $100,000 |
| 2026-03-30 | quarter | 2024-03-30 | $— | $-3.40 | ▼ 3.40 | $— | $300,000 |
Earnings Call Transcripts
No transcripts available.